Search - Université de Rennes Access content directly

Filter your results

10 Results
authFullName_s : Laurence Albiges
Image document

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

Aurélie Fluckiger , Romain Daillere , Mohamed Sassi , Barbara S Sixt , Peng Liu et al.
Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
Journal articles inserm-02923397v1
Image document

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Stéphane Terry , Cécile Dalban , Nathalie Rioux-Leclercq , Julien Adam , Maxime Meylan et al.
Clinical Cancer Research, 2021, 27 (24), pp.6749-60. ⟨10.1158/1078-0432.CCR-21-0972⟩
Journal articles hal-03477307v1

Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).

Jean-Jacques Patard , Jean-Christophe Bernard , Karim Bensalah , Hervé Baumert , Hervé Lang et al.
Journal of Clinical Oncology, 2016, 34 (2)
Journal articles hal-01361499v1

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting

Jean-Alexandre Long , Jean-Christophe Bernhard , Pierre Bigot , Cécilia Lanchon , Philippe Paparel et al.
World Journal of Urology, 2017, 35 (4), pp.649 - 656. ⟨10.1007/s00345-016-1913-4⟩
Journal articles hal-01792768v1

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status

Yosra Messai , Sophie Gad , Muhammad Zaeem Noman , Gwenael Le Teuff , Sophie Couve et al.
European Urology, 2016, 70 (4), pp.623-632. ⟨10.1016/j.eururo.2015.11.029⟩
Journal articles hal-01255838v1

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array

Laurence Albiges , Justine Guegan , Audrey Le Formal , Virginie Verkarre , Nathalie Rioux-Leclercq et al.
Clinical Cancer Research, 2014, 20 (13), pp.3411--3421. ⟨10.1158/1078-0432.CCR-13-2173⟩
Journal articles hal-01064619v1
Image document

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

Gwenaëlle Gravis , François Audenet , Jacques Irani , Marc-Olivier Timsit , Philippe Barthélémy et al.
Cancer Treatment Reviews, 2017, 55, pp.211-217. ⟨10.1016/j.ctrv.2016.09.008⟩
Journal articles hal-01632557v1
Image document

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial

Sylvie Négrier , Nathalie Rioux-Leclercq , Céline Ferlay , Marine Gross-Goupil , Gwénaelle Gravis et al.
European Journal of Cancer, 2020, 129, pp.107 - 116. ⟨10.1016/j.ejca.2020.02.001⟩
Journal articles hal-02552562v1

Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Genitales)

Mathilde Cancel , Gaelle Fromont , Cyriac Blonz , Christine Chevreau , Nathalie Rioux-Leclercq et al.
European Journal of Cancer, 2021, 158, pp.1-11. ⟨10.1016/j.ejca.2021.08.046⟩
Journal articles hal-03476711v1

Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma

Zine-Eddine Khene , Pierre Bigot , Nicolas Doumerc , Idir Ouzaid , R. Boissier et al.
European Urology Oncology, 2022, ⟨10.1016/j.euo.2022.07.007⟩
Journal articles hal-03775987v1